This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for COMIRNATY® Omicron XBB.1.5▼ (raxtozinameran) COVID-19 mRNA Vaccine and COMIRNATY® JN.1▼ (bretovameran) COVID-19 mRNA Vaccine Great Britain (GB) in the private market and PI for COMIRNATY® JN.1▼ (bretovameran) COVID-19 mRNA Vaccine Northern Ireland (NI) in the private market

​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe - PI for GB
  • COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, single dose vial COVID-19 mRNA Vaccine - PI for GB

Northern Ireland

  • COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe - PI for NI

COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe - PI for GB

COMIRNATY Omicron XBB.1.5 30 micrograms/dose dispersion for injection, single dose vial COVID-19 mRNA Vaccine - PI for GB

COMIRNATY JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe - PI for NI

PP-CMR-GBR-0645 August 2024